A 10-year-old boy with myasthenia gravis had severe post-thymectomy myasthenic crisis necessitating reintroduction of mechanical ventilation on the 5th day after thymectomy. He did not respond to therapy with oral pyridostigmine, corticosteroids, or high-dose intravenous immunoglobulin. Finally, in addition to the usual supportive care, he was treated successfully with continuous intravenous infusion of neostigmine. Continuous infusion of neostigmine was used for the first time in post-thymectomy myasthenic crisis in a child to the best of our knowledge. (J Child Neurol 2000; 15:747-749).
Get full access to this article
View all access options for this article.
References
1.
Stanley EF, Drachman DB: Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions. Science1978;200:1285-1286.
2.
Osserman KE, Genkins G.: Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients. Mt Sinai J Med1971; 38:497-534.
3.
Millichap JG , Dodge PR: Diagnosis and treatment of myasthenia gravis in infancy, childhood and adolescence: A study of 51 patients. Neurology1960;10:1007-1014.
4.
Gracy DR, Divertie MB, Howard FM: Mechanical ventilation for respiratory failure in myasthenia gravis . Mayo Clin Proc1983;58:597-602.
5.
Drachman DB: Myasthenia gravis. N Engl J Med1994 ;330:1797-1810.
6.
Loh L.: Neurological and neuromuscular disease. Br J Anaesth1986;58: 190-200.
7.
Sellman MS, Mayer RF: Treatment of myasthenic crisis in late life. South Med J1985;78:1208-1210.
8.
Szobor A.: Crisis in myasthenia gravis. Akadimia Kiado1970;7:71-74.
9.
Oates JA, Wood AJJ: Manipulating the immune system with immune globulin. N Engl J Med1992;326:107-116.
10.
Jongen JL, van Doorn PA, van der Meche FG: High-dose intravenous immunoglobulin therapy for myasthenia gravis . J Neurol1998;245: 26-31.
11.
Panegyres PK , Squier M., Mills KR, Newsom-Davis J.: Acute myopathy associated with large parenteral dose of corticosteroid in myasthenia gravis . J Neurol Neurosurg Psychiatry1993;56:702-704.
12.
Drachman DB : The biology of myasthenia gravis. Annu Rev Neurosci1981;4:195-225.
13.
Breyer-Pfaff U., Maier U., Brinkam AM, et al: Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis. Clin Pharmacol Ther1985;37:495-501.
14.
Saltis AM, Martin BR, Traeger SM, et al: Continuous infusion of pyridostigmine in the management of myasthenic crisis. Crit Care Med1993;21:938-940.
15.
Berrouschot J., Baumann I., Kalischewski P., et al: Therapy of myasthenic crisis. Crit Care Med1997;25:1228-1235.
16.
American Hospital Formulary Service: AHFS Drug Information '92. Bethesda, American Society of Hospital Pharmacists, 1992 , 622-632.
17.
Nicholson J. , Grant IS: Continuous infusion of pyridostigmine for myasthenic crisis. Crit Care Med1994;22:895-896.
18.
Miller RD, VanNyhuis LS, Eger EI, et al: Comparative times to peak effect and durations of action of neostigmine and pyridostigmine. Anesthesiology1974;41:27-33.
19.
Bingle JP, Rutherford JD, Woodrow P.: Continuous subcutaneous neostigmine in the management of severe myasthenia gravis. BMJ1979; 1:1050.
20.
Havard CWH , Fonseca V.: New treatment approaches to myasthenia gravis . Drugs1990;39:66-73.
21.
Milner-Brown HS, Mellenthin M., Sharma ML, et al: Quantitative correlation between plasma pyridostigmine and neuromuscular function in myasthenia gravis. Neurology1987;37:800-803.
22.
Borel CO: Management of myasthenic crisis: continuous anticholinesterase infusions . Crit Care Med1993;21:821-822.
23.
Masaoka A., Monden Y., Seike Y., et al: Reoperation after transcervical thymectomy for myasthenia gravis . Neurology1982;32:83-85.
24.
Lindberg C. , Andersen O., Larsson S., Oden A.: Remission rate after thymectomy in myasthenia gravis when the bias of immunosuppressive therapy is eliminated. Acta Neurol Scand1992;86:323-328.
25.
Blossom GB, Ernstoff RM, Howells GA, et al: Thymectomy for myasthenia gravis. Arch Surg1993;128:855-862.
26.
Adams C., Theodorescu D., Murphy EG, Shandling B.: Thymectomy in juvenile myasthenia gravis. J Child Neurol1990;5:215-218.
27.
Herrmann DN , Carney PR, Wald JJ: Juvenile myasthenia gravis: Treatment with inunune globulin and thymectomy. Pediatr Neurol1998;18: 63-66.
28.
Jaretzki A. , Penn AS, Younger DS, et al: "Maximal" thymectomy for myasthenia gravis. J Thorac Cardiovasc Surg1988;95:717-757.